Trademark Search in Canada

LYNDRA

View On IC.GC.CA

REGISTERED

on 13 Dec 2024

Last Applicant/ Owned by

Lyndra Therapeutics, Inc.

65 Grove Street, Suite 301Watertown MA 02472

Serial Number

2190760 filed on 1^st Feb 2022

Registration Number

TMA1275887 registered on 13^th Dec 2024

Registration expiry Date

1^st Feb 2032

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

LYNDRA

Trademark usage description

pharmaceutical preparations for human use for the treatment of allergies, autoimmune diseases, blood disorders, bone diseases, cardiovascular diseases Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment of allergies, autoimmune diseases, blood disorders, bone diseases, cardiovascular diseases, cerebrovascular diseases, diabetes, digestive diseases, gastrointestinal diseases, genetic disorders, hepatological diseases and disorders, hematological diseases and disorders, hormonal disorders, kidney diseases, liver diseases and disorders, migraines, headaches, pain, musculoskeletal disorders, ophthalmic diseases, oncological diseases and disorders, pulmonary diseases and disorders, respiratory diseases, renal disease and disorders, skin and nail diseases, and vascular diseases; Antivirals; Pharmaceutical preparations for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and bacterial skin infections and fungal skin infections; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; Pharmaceutical preparations for the treatment of neurological diseases, namely, myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of genitourinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; Pharmaceutical preparations for the treatment and prevention of HIV infection; Neurological and psychological pharmaceutical preparations for the treatment of drug addictions; Pharmaceutical preparations for the treatment and prevention of HIV infection; Contraceptive preparations; Pharmaceutical preparations for the treatment of malaria; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals.

Classification kind code

Class [042]
Medical and pharmacological research and development services in the field of drug delivery agents for regulating dosage forms for extended release pharmaceuticals; Pharmaceutical research and development services, namely, research and development in the field of drug delivery agents for the extended release of the active ingredients for a wide variety of pharmaceuticals.

Classification kind code

Mark Details

Serial Number

2190760

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 11^th Jan 2024	Agent Changed
Submitted for opposition 22 on 3^rd Aug 2023	Search Recorded
Submitted for opposition 20 on 3^rd Aug 2023	Examiner's First Report
Submitted for opposition 223 on 3^rd Aug 2023	Total Provisional Refusal
Submitted for opposition 256 on 10^th Apr 2023	Notification of Possible Opposition Sent
Submitted for opposition 257 on 9^th Jun 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 9^th Jun 2022	Created
Submitted for opposition 31 on 9^th Jun 2022	Formalized
Submitted for opposition 30 on 1^st Feb 2022	Filed
Submitted for opposition 228 on 1^st Feb 2022	International Registration